Globus Medical Reports Second Quarter 2019 Results
Globus Medical, Inc. Class A (GMED)
Last globus medical, inc. class a earnings: 2/20 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.globusmedical.com
Company Research
Source: GlobeNewswire
AUDUBON, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2019. Worldwide sales were $194.5 million, an increase of 12.2% as reported Second quarter net income was $38.2 million Diluted earnings per share (EPS) was $0.38 and non-GAAP diluted EPS was $0.41, a decrease of 6.7% Non-GAAP adjusted EBITDA was 32.0% of sales “Our strong second quarter results demonstrate solid momentum across all parts of our business," said Dave Demski, President and CEO. "Enabling Technologies contributed $12.0 million, down from last year’s $13.7 million, but up 67% over the first quarter; our International Spine business grew at 19.2%, on a constant currency basis; and our US Spine business continued to accelerate, growing at 11.7%." Worldwide sales for the second quarter were $194.5 million, an increase of 12.2% over the second quarter of 2018 on an as-
Show less
Read more
Impact Snapshot
Event Time:
GMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMED alerts
High impacting Globus Medical, Inc. Class A news events
Weekly update
A roundup of the hottest topics
GMED
News
- ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio [Yahoo! Finance]Yahoo! Finance
- Globus Medical, Inc. (NYSE: GMED) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Globus Medical Stock: Re-Rated After A Solid Year [Seeking Alpha]Seeking Alpha
- Globus Medical (GMED) is a Top-Ranked Momentum Stock: Should You Buy? [Yahoo! Finance]Yahoo! Finance
- Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think "Yes" [Yahoo! Finance]Yahoo! Finance
GMED
Earnings
- 11/5/24 - Beat
GMED
Sec Filings
- 11/21/24 - Form 144
- 11/21/24 - Form 144
- 11/21/24 - Form 144
- GMED's page on the SEC website